Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In this trial, the safety of combination treatment of Adriamycin plus cyclophosphamide
followed by Abraxane as adjuvant therapy will be evaluated in patients with limited stage
breast cancer.